Share This

Public company info - Ascentage Pharma Group International , 06855.HK

Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Ascentage Pharma Group International, 06855.HK - Profit Loss 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12
Turnover 209,711 27,910 12,450 14,513 6,807 6,328 7,667
Operating Profit -887,172 -832,249 -675,448 -1,482,316 -346,909 -120,116 -107,839
Exceptional Items 0 0 0 0 0 0 0
Associates 0 0 0 0 0 0 0
Profit Before Taxation -887,172 -832,249 -675,448 -1,482,316 -346,909 -120,116 -107,839
Taxation -4,248 -49,825 2,158 -1,602 -1,602 -1,602 0
Minority Interests 0 0 0 0 0 0 0
Net Profit -882,924 -782,424 -677,606 -1,480,714 -345,307 -118,514 -107,839
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Major Items
Depreciation 62,915 28,326 27,422 26,433 18,462 12,501 1,547
Interest Paid 67,392 37,634 11,482 4,274 36,919 57,938 3,259
Interest Capitalized 14,607 20,903 5,227 0 0 0 0
Non-current Assets Revaluation / Disposal 0 0 0 0 0 0 0
Taxation Rate (%) 0.48 5.99 -0.32 0.11 0.46 1.33
Turnover Growth (%) 651.38 124.18 -14.21 113.21 7.57 -17.46 0.0
Net Profit Growth (%) -12.84 -15.47 54.24 -328.81 -191.36 -9.9 0.0
Auditor's Opinion 1 1 1 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.